

🎁 12 AI Skills to Learn in 2026 (FREE Courses + Video Resources Included) Most people will use AI. The top 1% will build with it. 🎯If you learn these 12 skills in 2026, you'll be ahead of 95% of the market. Bookmark this🔖 Here's the roadmap 👇🧵
Professional_Tech_AI
6.3K posts

@LaboniIsla129
⭐Digital Entrepreneur | Empowering income growth through Al, tech tools, and online business. DM for Collaboration or Email me⤵️ [email protected]


🎁 12 AI Skills to Learn in 2026 (FREE Courses + Video Resources Included) Most people will use AI. The top 1% will build with it. 🎯If you learn these 12 skills in 2026, you'll be ahead of 95% of the market. Bookmark this🔖 Here's the roadmap 👇🧵





🎁 12 AI Skills to Learn in 2026 (FREE Courses + Video Resources Included) Most people will use AI. The top 1% will build with it. 🎯If you learn these 12 skills in 2026, you'll be ahead of 95% of the market. Bookmark this🔖 Here's the roadmap 👇🧵






Learn AI for free directly from top companies. 1 - Anthropic: anthropic.skilljar.com 2 - Google: grow.google/ai 3 - Meta: ai.meta.com/resources/ 4 - NVIDIA: developer.nvidia.com/cuda 5 - Microsoft: learn.microsoft.com/en-us/training/ 6 - OpenAI: academy.openai.com 7 - IBM: skillsbuild.org 8 - AWS: skillbuilder.aws 9 - DeepLearning.AI: deeplearning.ai 10 - Hugging Face: huggingface.co/learn 👇Comment "Learning" if you find this helpful. Repost ♻️ so others can take help. Must bookmark for future reference.





some time back, i fell into a peptide rabbit hole. read everything. started experimenting. couldn't stop. then India's semaglutide patent expired in march. 25+ generics launched overnight. suddenly one of the most powerful drugs in healthcare was accessible - but nobody had built proper infrastructure around it. no GLP-1 specialists. no monitoring. no cold chain. 1 in 4 indian adults overweight or obese and the system just wasn't ready. so we built @ZeltaHealth, doctor-prescribed GLP-1s with full medical oversight, delivery, follow-ups, nutrition, blood work - the whole stack. 5,000+ registered patients later, linking up with the head of BD at Novo Nordisk - the company that pioneered GLP-1s with Ozempic and Wegovy. the peptide space in India is just getting interesting. a lot more to come.